Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 9, 2019
Event: Unregistered Sales of Equity Securities (Item 3.02)
Key Financial Metrics
This filing reports a specific capital raise event rather than periodic financial performance metrics (e.g., revenue, profit, or cash flow).
| Metric | Value |
|---|---|
| Shares Issued | 1,212,121 Class A common stock |
| Price Per Share | $1.65 |
| Total Proceeds | $2.0 million |
| Investor | MacAndrews & Forbes Group LLC |
Material Changes
The Company exercised a right under a letter agreement dated March 18, 2019, to require the Investor to purchase the aforementioned shares. This transaction increased the Company's cash position by $2.0 million and increased the outstanding share count by 1,212,121 shares.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the transaction is qualified by reference to the March 2019 Letter Agreement (Exhibit 10.2 to the March 20, 2019 Form 8-K).
Investor Verification Checklist
- Verify the terms of the March 2019 Letter Agreement referenced in the filing.
- Confirm the updated total number of outstanding shares post-transaction.
- Review the Company's cash burn rate to assess the runway provided by the $2.0 million infusion.
- Check for any subsequent filings regarding the use of proceeds from this capital raise.